Mitre Medical


Mitre Medical Corp. Retains Zimmons International Communications, Inc. for Investor Relations Activities

August 27, 2020 – Morgan Hill, CA – Mitre Medical Corp. (“Mitre Medical” or “company”), an early-stage medical device company developing the Mitral Touch®, a less invasive and safer approach to treat mitral valve regurgitation (MR) and remodel the left ventricle (LV) in patients with moderate to severe MR, has retained Zimmons International Communications, Inc. (“Zimmons International”), based in New York City, as the company’s financial communications counselor and investor relations firm.

Zimmons International will assist Mitre Medical in developing and managing investor relations initiatives and activities aimed at raising Mitre Medical’s corporate profile among investors.  Specific emphasis will be on increasing the awareness of Mitre Medical among family offices, specialized healthcare funds, and strategic entities.

“As Mitre Medical works with the FDA and progresses with clinical trials to introduce Mitral Touch® to US doctors and patients, we believe now is the time to start communicating our opportunity.  Retaining an investor relations and communications expert is a strategic step.  Currently, Zimmons International is working with Mitre Medical to identify family offices, specialized healthcare funds, and investors with an interest in emerging healthcare technologies.  As Mitre Medical advances its business, we feel that informing the financial community of our achievements will provide investors with the most timely and up-to-date information to make an investment decision,” stated John MacMahon, Chief Executive Officer of Mitre Medial.

“I am delighted to be working with Mitre Medical, especially during this pivotal inflection point in the company’s history.  Cardiovascular health is a major issue for patients and doctors in the global healthcare system.  Supporting Mitre Medical with its investor awareness efforts will in turn help Mitre Medical achieve its goal of offering an innovative solution that can help millions of patients,” stated Jennifer K. Zimmons, Ph.D., President of Zimmons International.

About Mitre Medical Corp.

Mitre Medical Corp is an early-stage medical device company developing the Mitral Touch®, a less invasive and safer approach to treat mitral valve regurgitation (MR) and remodel the left ventricle (LV) in patients with moderate to severe MR. Mitre Medical has the potential to be the new standard of care for MR.  For more information, please visit

About Zimmons International Communications, Inc.

Zimmons International Communications, Inc. (“ZIC”) is a boutique investor relations firm based in New York founded by Jennifer K. Zimmons, Ph.D.  ZIC specializes in working with international companies as well as with portfolio companies of family offices and private equity firms.  Clients include both public and private entities. ZIC’s client base is composed of emerging healthcare opportunities as well as technology, resources, and consumer health companies.  Dr. Zimmons also serves as the Program Committee Chair for Women in BIO (New York Chapter) as well as board member for a family office focusing on emerging and frontier markets. For more information, please visit

Forward Looking Statements
This press release includes forward-looking statements including, but not limited to, statements related to the development of our technology, our operations and business strategy, our expected financial results, and corporate updates. The forward-looking statements contained in this press release are based on management’s current expectations and are subject to substantial risks, uncertainty and changes in circumstances. Actual results may differ materially from those expressed by these expectations due to risks and uncertainties. Forward-looking statements speak only as of the date of this press release, and we undertake no obligation to review or update any forward-looking statement except as may be required by applicable law.

Mitre Medical Corp.:

John MacMahon

Chief Executive Officer
18655 Madrone Parkway
Morgan Hill, CA 95037
Tel: +1 603.264.7751

Investor Contact:

Jennifer K. Zimmons, Ph.D.
Investor Relations
Zimmons International Communications
Tel: +1 917.214.3514

Jennifer K. Zimmons, Ph.D., serves as President of Zimmons International Communications, Inc., (ZIC) managing  all aspects of client services. Clients include private companies looking to develop/enhance their brand awareness, corporate messaging, and media recognition (industry/financial/advocacy) as well as public companies (domestic and international) requiring various types of investor, analyst, and media exposure within the US.  Ms. Zimmons is also a consultant to US/international family offices, venture capitalists, and private equity groups to manage the branding and positioning of their portfolio companies.  She is a  member of the press, serves as Program Co-Chair for Women in Bio (New York Chapter), and is a Board Advisor to a leading internationally-focused, emerging-markets family office/buy-side fund based in Washington, DC.

Ms. Zimmons served as Managing Director at Cooper Global Communications, LLC. (previously named Strategic Growth) where she originated client relationships and managed all aspects of client services including: industry analysis, media, advocacy group outreach, development of financial/corporate materials, road show orchestration, conference participation, uplistings, analyst coverage, and assistance with capital raising.

Industry expertise includes healthcare, technology, energy, and select break-out opportunities.  Ms. Zimmons is considered a pioneer in introducing many successful Australian and OTCQX-listed companies to US investors.  She is an active participant and strong supporter of many women-in-business initiatives, Australian/international organizations, as well as art/cultural/style events in the New York area.   She has been a featured keynote speaker and panelist at several financial and women-in-business events.

Ms. Zimmons holds an MBA from American University, a Ph.D. from Texas Tech University, and a Bachelor of Arts from Marymount University.

Source: Mitre Medical Corp.